The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

Barclays upgrades CVS Health to Overweight, citing gains in pharmacy market share and potential upside from CostVantage. CVS is expected to recover 200 basis points in Medicare margins by 2026 ...

The most recent trading session ended with CVS Health (CVS) standing at $54.55, reflecting a +1.36% shift from the previouse trading day's closing. The stock's performance was ahead of the S&P 500 ...

If you’ve filled a prescription in the past decade, you’re probably familiar with at least one pharmacy benefit manager. The “big three” PBMs are Express Scripts, CVS Caremark and Optum Rx.

The big health insurers Moody's rates now face shrinking profit margins at the Medicaid plans they manage for state ...

CVS Pharmacy is the first national retail pharmacy chain to announce the removal of partially hydrogenated oils (PHO), the primary source of artificial trans fats in processed foods, from all its ...

CVS Pharmacy has announced plans to open a new kind of store in parts of the U.S. The pharmacy chain said it will open "smaller format" locations in select communities within the next year. Stream ...

Barclays upgraded CVS Health Inc (NYSE:CVS) on higher Pharmacy & Consumer Wellness (PCW) estimates as headwinds are offset by share gains, with further upside potential from CostVantage. Despite ...